MarginsXMarginsX
Home › Canada › CSE stocks › VREO

Vireo Growth Inc. (CSE: VREO)

VREO trades on the Canadian Securities Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$8.79
-8.91% on the day
Market cap (C$)
C$502.1M
TMX list, November 13, 2026
Market cap (US$)
US$352.2M
Small cap at 1.4257 C$/US$
1-year return
-60.9%
-64.7% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for VREO.CN, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerVREO on the Canadian Securities Exchange
Yahoo symbolVREO.CN
SectorLife Sciences, Drug Manufacturers—Specialty & Generic
HeadquartersBritish Columbia
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding57,117,981
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001771706
WebsiteNo company website on record

Returns

WindowReturn
1 day-8.9%
1 week-4.5%
1 month-30.7%
3 months-41.4%
6 months-47.7%
Year to date-64.7%
1 year-60.9%
From 52-week high-67.4%
52-week rangeC$8.79 to C$27.00

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

332 documents in 11 types. Each title links to the document at its source.

Annual financial statements (2)

Interim financial statements (7)

News release (42)

Management information circular / proxy (6)

DocumentTypeFiled
DEF 14AProxy statement (DEF 14A)2026-04-16
DEFA14AProxy statement (DEFA14A)2026-04-16
PRE 14AProxy statement (PRE 14A)2026-04-06
DEF 14AProxy statement (DEF 14A)2025-05-09

Prospectus (6)

DocumentTypeFiled
S-4/ARegistration statement (S-4/A)2026-10-30
S-4Registration statement (S-4)2026-10-09
FORM S-3Registration statement (S-3)2026-04-23
FORM S-3Registration statement (S-3)2025-12-09

Annual report (2)

DocumentTypeFiled
10-K
Period 2025-12-31
Annual report (10-K) (10-K)2026-03-17
10-K
Period 2024-12-31
Annual report (10-K) (10-K)2025-03-04

Quarterly report (7)

DocumentTypeFiled
10-Q
Period 2026-09-30
Quarterly report (10-Q) (10-Q)2026-11-12
10-Q
Period 2026-06-30
Quarterly report (10-Q) (10-Q)2026-08-14
10-Q
Period 2026-03-31
Quarterly report (10-Q) (10-Q)2026-05-12
10-Q
Period 2025-09-30
Quarterly report (10-Q) (10-Q)2025-11-12

Early warning / ownership (9)

DocumentTypeFiled
Schedule 13D amendmentSchedule 13D (SCHEDULE 13D/A)2026-11-10
Schedule 13DSchedule 13D (SCHEDULE 13D)2025-08-01
Schedule 13DSchedule 13D (SCHEDULE 13D)2025-05-23
Schedule 13D amendmentSchedule 13D (SCHEDULE 13D/A)2025-04-22

Insider report (55)

DocumentTypeFiled
Form 3Form 3 (3)2026-11-13
Form 3Form 3 (3)2026-11-13
Form 3Form 3 (3)2026-06-08
Form 3Form 3 (3)2026-04-07

Certification (27)

DocumentTypeFiled
EX-31.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12
EX-31.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12
EX-32.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12
EX-32.1
Period 2026-06-30
Certification (SOX 302/906) (10-Q)2026-08-14

Other (169)

DocumentTypeFiled
8-KCurrent report (8-K) (8-K)2026-11-10
FORM 8-KCurrent report (8-K) (8-K)2026-10-08
FORM 8-KCurrent report (8-K) (8-K)2026-08-26
FORM 8-KCurrent report (8-K) (8-K)2026-08-18

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

Trading: the last notice, on 2026-06-05, was a resumption.

NoticeActionReasonNotice
2026-06-05 9:30 AM ETResumptionNo reason statedCIRO notice
2026-06-05 8:36 AM ETHaltDue to Imbalance of OrdersCIRO notice
2025-09-04 10:00 AM ETResumptionNo reason statedCIRO notice
2025-09-03 3:38 PM ETHaltPending Company ContactCIRO notice

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Recent

DateTimeEventWebcastSource
2026-11-10No time in the announcementQ3 earnings releaseNo webcast link announcedSEC filing
2026-11-108:00 a.m. ETQ3 earnings callWebcastSEC filing

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2026-10-07EquityUS$7.5MUS$7.5MSEC EDGAR
2026-10-02EquityUS$210KUS$210KSEC EDGAR
2026-08-24Equity, Option To Acquire, OtherUS$47.7MUS$48.7MSEC EDGAR
2026-06-29Equity, Debt, OtherUS$1.1MUS$1.1MSEC EDGAR
2026-06-22Debt, Option To Acquire, Security To Be Acquired, OtherUS$13.7MUS$13.7MSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
SNDLSNDL Inc.CSEC$510.9M+16.2%-18.5%
FRXFennec Pharmaceuticals Inc.TSXC$522.2M+14.3%+50.8%
EPRXEupraxia Pharmaceuticals Inc.TSXC$640.1M+21.5%+32.7%
WEEDCanopy Growth CorporationTSXC$393.7M-25.0%-47.1%
ACBAurora Cannabis Inc.TSXC$372.0M+15.4%+14.4%

The app has the price chart, every filing, private raises and the full peer set for VREO.

Open in the app